{"transactions":[{"id":3362257,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":2068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2068},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362256,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":4756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4756},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362255,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362254,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362253,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":13266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":77.38,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":13266},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362252,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":121.04,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362251,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":99.98,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362250,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":112.16,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362249,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":20700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":88.5,"expiration_date":"2024-07-01","underlying":"Common Stock","underlying_shares":20700},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362248,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":18600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":59.06,"expiration_date":"2023-06-12","underlying":"Common Stock","underlying_shares":18600},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362247,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":18600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":31.8,"expiration_date":"2022-06-13","underlying":"Common Stock","underlying_shares":18600},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362246,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":18600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":29,"expiration_date":"2021-06-15","underlying":"Common Stock","underlying_shares":18600},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362245,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":24666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":27.69,"expiration_date":"2020-06-16","underlying":"Common Stock","underlying_shares":24666},"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362244,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 2, 2019, by and among Celgene Corporation (\"Celgene\"), Bristol-Myers Squibb Company (\"BMS\"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the \"Effective Time\"), each share of Celgene common stock was converted into the right to receive (i) $50.00 in cash, (ii) one share of BMS common stock, and (iii) one contingent value right (\"CVR\") issued by BMS subject to and in accordance with the CVR agreement, dated November 20, 2019, by and between BMS and the Equiniti Trust Company."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3362243,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T07:30:59.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":41861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 2, 2019, by and among Celgene Corporation (\"Celgene\"), Bristol-Myers Squibb Company (\"BMS\"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the \"Effective Time\"), each share of Celgene common stock was converted into the right to receive (i) $50.00 in cash, (ii) one share of BMS common stock, and (iii) one contingent value right (\"CVR\") issued by BMS subject to and in accordance with the CVR agreement, dated November 20, 2019, by and between BMS and the Equiniti Trust Company."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-19-001371","document":"form4-11222019_071146.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001371/form4-11222019_071146.xml","form_type":"4"}},{"id":3474698,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true}}],"security":"Stock Option (Right To Purchase)","published_at":"2019-07-01T20:42:59.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the option shall vest upon each of the first, second, and third anniversaries of the date of grant, such that the option will be fully vested on June 28, 2022."}],"balance_after":9000,"derivative":{"exercise_price":5.99,"expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001127602-19-023235","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760219023235/form4.xml","form_type":"4"}},{"id":3488735,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-17T16:00:29.000Z","date":"2019-06-15","kind":"exercise","acquired":false,"shares":2066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2011 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"The remainder of the restricted stock units will vest as follows: 2,068 shares on June 15, 2020. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2011 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2011 vested and settled for shares of the Company's common stock."}],"balance_after":2068,"derivative":{"underlying":"Common Stock","underlying_shares":2066},"source":{"system":"sec-edgar","filing":"0001415889-19-000728","document":"form4-06172019_040615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000728/form4-06172019_040615.xml","form_type":"4"}},{"id":3488734,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-17T16:00:29.000Z","date":"2019-06-15","kind":"exercise","acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001415889-19-000728","document":"form4-06172019_040615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000728/form4-06172019_040615.xml","form_type":"4"}},{"id":3488733,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-17T16:00:29.000Z","date":"2019-06-14","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The remainder of the restricted stock units will vest as follows: 300 shares on June 14, 2020. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."}],"balance_after":300,"derivative":{"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001415889-19-000728","document":"form4-06172019_040615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000728/form4-06172019_040615.xml","form_type":"4"}},{"id":3488732,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-17T16:00:29.000Z","date":"2019-06-13","kind":"exercise","acquired":false,"shares":484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The remainder of the restricted stock units will vest in two annual installments as follows: 485 shares on June 13, 2020 and 485 shares on June 13, 2021. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."}],"balance_after":970,"derivative":{"underlying":"Common Stock","underlying_shares":484},"source":{"system":"sec-edgar","filing":"0001415889-19-000728","document":"form4-06172019_040615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000728/form4-06172019_040615.xml","form_type":"4"}},{"id":3488731,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T16:00:29.000Z","date":"2019-06-15","kind":"exercise","acquired":true,"shares":2066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2011 vested and settled for shares of the Company's common stock."}],"balance_after":41861,"source":{"system":"sec-edgar","filing":"0001415889-19-000728","document":"form4-06172019_040615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000728/form4-06172019_040615.xml","form_type":"4"}},{"id":3488730,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T16:00:29.000Z","date":"2019-06-15","kind":"exercise","acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":39795,"source":{"system":"sec-edgar","filing":"0001415889-19-000728","document":"form4-06172019_040615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000728/form4-06172019_040615.xml","form_type":"4"}},{"id":3488729,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T16:00:29.000Z","date":"2019-06-14","kind":"exercise","acquired":true,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."}],"balance_after":39420,"source":{"system":"sec-edgar","filing":"0001415889-19-000728","document":"form4-06172019_040615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000728/form4-06172019_040615.xml","form_type":"4"}},{"id":3488728,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T16:00:29.000Z","date":"2019-06-13","kind":"exercise","acquired":true,"shares":484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."}],"balance_after":39120,"source":{"system":"sec-edgar","filing":"0001415889-19-000728","document":"form4-06172019_040615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000728/form4-06172019_040615.xml","form_type":"4"}},{"id":3501339,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-05T16:05:37.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":4756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in three annual installments as follows: 1,585 shares on June 3, 2020; 1,585 shares on June 3, 2021; and 1,586 shares on June 3, 2022.  Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest in three annual installments as follows: 1,585 shares on June 3, 2020; 1,585 shares on June 3, 2021; and 1,586 shares on June 3, 2022.  Vested shares will be delivered to the reporting person promptly after the vesting date."}],"balance_after":4756,"derivative":{"underlying":"Common Stock","underlying_shares":4756},"source":{"system":"sec-edgar","filing":"0001415889-19-000665","document":"form4-06052019_040624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000665/form4-06052019_040624.xml","form_type":"4"}},{"id":3590491,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-03-18T21:47:34.000Z","date":"2019-03-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-19-011927","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760219011927/form4.xml","form_type":"4"}},{"id":3590490,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-18T21:47:34.000Z","date":"2019-03-15","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."}],"balance_after":26625,"source":{"system":"sec-edgar","filing":"0001127602-19-011927","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760219011927/form4.xml","form_type":"4"}},{"id":3666783,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-11T16:05:14.000Z","date":"2019-02-07","kind":"exercise","acquired":false,"shares":24666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":22.47,"expiration_date":"2019-06-17","underlying":"Common Stock","underlying_shares":24666},"source":{"system":"sec-edgar","filing":"0001415889-19-000144","document":"form4-02112019_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000144/form4-02112019_040201.xml","form_type":"4"}},{"id":3666782,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-11T16:05:14.000Z","date":"2019-02-07","kind":"sale","acquired":false,"shares":23466,"price":87.289,"value":2048323.674,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold by the reporting person in multiple transactions at prices ranging from $87.28 to $87.30, inclusive. The reporting person undertakes to provide Celgene Corporation (the \"Company\"), any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":38636,"source":{"system":"sec-edgar","filing":"0001415889-19-000144","document":"form4-02112019_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000144/form4-02112019_040201.xml","form_type":"4"}},{"id":3666781,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-11T16:05:14.000Z","date":"2019-02-07","kind":"exercise","acquired":true,"shares":24666,"price":22.47,"value":554245.02,"ownership":{"direct":true},"balance_after":62102,"source":{"system":"sec-edgar","filing":"0001415889-19-000144","document":"form4-02112019_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000144/form4-02112019_040201.xml","form_type":"4"}},{"id":3843288,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-08-15T12:03:38.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-18-025374","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760218025374/form4.xml","form_type":"4"}},{"id":3887135,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true}}],"security":"Stock Option (Right To Purchase)","published_at":"2018-06-20T20:28:45.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These options expire on the third anniversary of the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":1.1,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127602-18-021582","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760218021582/form4.xml","form_type":"4"}},{"id":3891661,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-18T16:00:32.000Z","date":"2018-06-17","kind":"exercise","acquired":false,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":334},"source":{"system":"sec-edgar","filing":"0001415889-18-000950","document":"form4-06182018_040615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000950/form4-06182018_040615.xml","form_type":"4"}},{"id":3891660,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-18T16:00:32.000Z","date":"2018-06-17","kind":"exercise","acquired":true,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."}],"balance_after":37436,"source":{"system":"sec-edgar","filing":"0001415889-18-000950","document":"form4-06182018_040615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000950/form4-06182018_040615.xml","form_type":"4"}},{"id":3893116,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-15T16:13:43.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":2066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2011 vested and such vested restricted stock units settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"The remainder of the restricted stock units will vest in annual installments as follows: 2,066 shares on June 15, 2019 and 2,068 shares on June 15, 2020. Vested shares will be delivered promptly to the reporting person after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2011 vested and such vested restricted stock units settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2011 vested and such vested restricted stock units settled for shares of the Company's common stock."}],"balance_after":4134,"derivative":{"underlying":"Common Stock","underlying_shares":2066},"source":{"system":"sec-edgar","filing":"0001415889-18-000935","document":"form4-06152018_010627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000935/form4-06152018_010627.xml","form_type":"4"}},{"id":3893115,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-15T16:13:43.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"One-third of the restricted stock units granted to the reporting person June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"The remainder of the restricted stock units will vest on June 15, 2019. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the restricted stock units granted to the reporting person June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third of the restricted stock units granted to the reporting person June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":375,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001415889-18-000935","document":"form4-06152018_010627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000935/form4-06152018_010627.xml","form_type":"4"}},{"id":3893114,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-15T16:13:43.000Z","date":"2018-06-14","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"The remainder of the restricted stock units will vest in two annual installments as follows: 300 shares on June 14, 2019 and 300 shares on June 14, 2020. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."}],"balance_after":600,"derivative":{"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001415889-18-000935","document":"form4-06152018_010627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000935/form4-06152018_010627.xml","form_type":"4"}},{"id":3893113,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-15T16:13:43.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":13266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Option is immediately exercisable and will vest on the earlier of June 13, 2019 or the day preceding the date of the next stockholder meeting."}],"balance_after":13266,"derivative":{"exercise_price":77.38,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":13266},"source":{"system":"sec-edgar","filing":"0001415889-18-000935","document":"form4-06152018_010627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000935/form4-06152018_010627.xml","form_type":"4"}},{"id":3893112,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-15T16:13:43.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":1454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest in three annual installments as follows: 484 shares on June 13, 2019; 485 shares on June 13, 2020; and 485 shares on June 13, 2021. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units will vest in three annual installments as follows: 484 shares on June 13, 2019; 485 shares on June 13, 2020; and 485 shares on June 13, 2021. Vested shares will be delivered to the reporting person promptly after the vesting date."}],"balance_after":1454,"derivative":{"underlying":"Common Stock","underlying_shares":1454},"source":{"system":"sec-edgar","filing":"0001415889-18-000935","document":"form4-06152018_010627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000935/form4-06152018_010627.xml","form_type":"4"}},{"id":3893111,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T16:13:43.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":2066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2011 vested and such vested restricted stock units settled for shares of the Company's common stock."}],"balance_after":37102,"source":{"system":"sec-edgar","filing":"0001415889-18-000935","document":"form4-06152018_010627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000935/form4-06152018_010627.xml","form_type":"4"}},{"id":3893110,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T16:13:43.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"One-third of the restricted stock units granted to the reporting person June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":35036,"source":{"system":"sec-edgar","filing":"0001415889-18-000935","document":"form4-06152018_010627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000935/form4-06152018_010627.xml","form_type":"4"}},{"id":3893109,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T16:13:43.000Z","date":"2018-06-14","kind":"exercise","acquired":true,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."}],"balance_after":34661,"source":{"system":"sec-edgar","filing":"0001415889-18-000935","document":"form4-06152018_010627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000935/form4-06152018_010627.xml","form_type":"4"}},{"id":3906871,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-05T16:15:17.000Z","date":"2018-06-04","kind":"exercise","acquired":false,"shares":27750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":30.01,"expiration_date":"2018-06-18","underlying":"Common Stock","underlying_shares":27750},"source":{"system":"sec-edgar","filing":"0001415889-18-000872","document":"form4-06052018_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000872/form4-06052018_040601.xml","form_type":"4"}},{"id":3906870,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T16:15:17.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":17750,"price":78.96,"value":1401540.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $78.61 to $79.16, inclusive. The reporting person undertakes to provide to Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":34361,"source":{"system":"sec-edgar","filing":"0001415889-18-000872","document":"form4-06052018_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000872/form4-06052018_040601.xml","form_type":"4"}},{"id":3906869,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T16:15:17.000Z","date":"2018-06-04","kind":"exercise","acquired":true,"shares":27750,"price":30.01,"value":832777.5,"ownership":{"direct":true},"balance_after":52111,"source":{"system":"sec-edgar","filing":"0001415889-18-000872","document":"form4-06052018_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000872/form4-06052018_040601.xml","form_type":"4"}},{"id":3999719,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-13T16:22:34.000Z","date":"2018-03-12","kind":"exercise","acquired":false,"shares":9250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued pursuant to the Company's 1995 Non-Employee Directors' Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":27.18,"expiration_date":"2018-03-17","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001209191-18-019209","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919118019209/doc4.xml","form_type":"4"}},{"id":3999718,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-13T16:22:34.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":9250,"price":92.01,"value":851092.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $91.46 to $92.47, inclusive.  The reporting person undertakes to provide to Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":24361,"source":{"system":"sec-edgar","filing":"0001209191-18-019209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919118019209/doc4.xml","form_type":"4"}},{"id":3999717,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-13T16:22:34.000Z","date":"2018-03-12","kind":"exercise","acquired":true,"shares":9250,"price":27.18,"value":251415.0,"ownership":{"direct":true},"balance_after":33611,"source":{"system":"sec-edgar","filing":"0001209191-18-019209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919118019209/doc4.xml","form_type":"4"}},{"id":4266273,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-07-05T19:33:00.000Z","date":"2017-07-01","kind":"exercise","acquired":false,"shares":734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated on April 15, 2015))."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":734},"source":{"system":"sec-edgar","filing":"0001209191-17-043766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117043766/doc4.xml","form_type":"4"}},{"id":4266272,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T19:33:00.000Z","date":"2017-07-01","kind":"exercise","acquired":true,"shares":734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock."}],"balance_after":24361,"source":{"system":"sec-edgar","filing":"0001209191-17-043766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117043766/doc4.xml","form_type":"4"}},{"id":4272133,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-27T16:39:17.000Z","date":"2017-06-26","kind":"exercise","acquired":false,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":33.88,"expiration_date":"2017-09-17","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001209191-17-041954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041954/doc4.xml","form_type":"4"}},{"id":4272132,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-27T16:39:17.000Z","date":"2017-06-26","kind":"exercise","acquired":false,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":24.97,"expiration_date":"2017-12-17","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001209191-17-041954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041954/doc4.xml","form_type":"4"}},{"id":4272131,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-27T16:39:17.000Z","date":"2017-06-26","kind":"sale","acquired":false,"shares":9250,"price":133.57,"value":1235522.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan in multiple transactions at prices ranging from $132.86 to $134.35, inclusive. The reporting person undertakes to provide Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":23627,"source":{"system":"sec-edgar","filing":"0001209191-17-041954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041954/doc4.xml","form_type":"4"}},{"id":4272130,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-27T16:39:17.000Z","date":"2017-06-26","kind":"exercise","acquired":true,"shares":9250,"price":33.88,"value":313390.0,"ownership":{"direct":true},"balance_after":32877,"source":{"system":"sec-edgar","filing":"0001209191-17-041954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041954/doc4.xml","form_type":"4"}},{"id":4272129,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-27T16:39:17.000Z","date":"2017-06-26","kind":"sale","acquired":false,"shares":9250,"price":133.57,"value":1235522.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan in multiple transactions at prices ranging from $132.86 to $134.35, inclusive. The reporting person undertakes to provide Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":23627,"source":{"system":"sec-edgar","filing":"0001209191-17-041954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041954/doc4.xml","form_type":"4"}},{"id":4272128,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-27T16:39:17.000Z","date":"2017-06-26","kind":"exercise","acquired":true,"shares":9250,"price":24.97,"value":230972.5,"ownership":{"direct":true},"balance_after":32877,"source":{"system":"sec-edgar","filing":"0001209191-17-041954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041954/doc4.xml","form_type":"4"}},{"id":4275262,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true}}],"security":"Stock Option (right To Purchase)","published_at":"2017-06-21T18:22:11.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":15000,"price":10.15,"value":152250.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":10.15,"exercise_date":"2018-06-20","expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127602-17-021951","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760217021951/form4.xml","form_type":"4"}},{"id":4276709,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-06-20T16:08:50.000Z","date":"2017-06-17","kind":"exercise","acquired":false,"shares":333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The balance of the restricted stock units will vest on June 17, 2018.  Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated on April 15, 2015))."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."}],"balance_after":334,"derivative":{"underlying":"Common Stock","underlying_shares":333},"source":{"system":"sec-edgar","filing":"0001209191-17-041069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041069/doc4.xml","form_type":"4"}},{"id":4276708,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-20T16:08:50.000Z","date":"2017-06-17","kind":"exercise","acquired":true,"shares":333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."}],"balance_after":23627,"source":{"system":"sec-edgar","filing":"0001209191-17-041069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041069/doc4.xml","form_type":"4"}},{"id":4279971,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-06-16T16:10:37.000Z","date":"2017-06-15","kind":"exercise","acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The remainder of the restricted stock units will vest as follows: 375 shares on June 15, 2018; 375 shares on June 15, 2019. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":750,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001209191-17-040462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117040462/doc4.xml","form_type":"4"}},{"id":4279970,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-06-16T16:10:37.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest in three equal annual installments commencing on June 14, 2018. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units will vest in three equal annual installments commencing on June 14, 2018. Vested shares will be delivered to the reporting person promptly after the vesting date."}],"balance_after":900,"derivative":{"underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001209191-17-040462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117040462/doc4.xml","form_type":"4"}},{"id":4279969,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-16T16:10:37.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option is immediately exercisable and will vest on the earlier of June 14, 2018 or the day preceding the date of the next annual stockholder meeting."}],"balance_after":10500,"derivative":{"exercise_price":121.04,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-17-040462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117040462/doc4.xml","form_type":"4"}},{"id":4279968,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-16T16:10:37.000Z","date":"2017-06-15","kind":"exercise","acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":23294,"source":{"system":"sec-edgar","filing":"0001209191-17-040462","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117040462/doc4.xml","form_type":"4"}},{"id":4339035,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-02T16:20:02.000Z","date":"2017-05-01","kind":"exercise","acquired":false,"shares":9250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was issued pursuant to the Company's 1995 Non-Employee Directors' Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":28.96,"expiration_date":"2017-06-12","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001209191-17-029190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117029190/doc4.xml","form_type":"4"}},{"id":4339034,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-02T16:20:02.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":9250,"price":124,"value":1147000.0,"ownership":{"direct":true},"balance_after":22919,"source":{"system":"sec-edgar","filing":"0001209191-17-029190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117029190/doc4.xml","form_type":"4"}},{"id":4339033,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-02T16:20:02.000Z","date":"2017-05-01","kind":"exercise","acquired":true,"shares":9250,"price":28.96,"value":267880.0,"ownership":{"direct":true},"balance_after":32169,"source":{"system":"sec-edgar","filing":"0001209191-17-029190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117029190/doc4.xml","form_type":"4"}},{"id":4397385,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":153629,"kind":"person","name":"LOUGHLIN JAMES J","position":1,"cik":"0001276550","reported_name":"LOUGHLIN JAMES J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-03-07T20:33:13.000Z","date":"2017-03-06","kind":"purchase","acquired":true,"shares":3000,"price":9.24,"value":27720.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001127602-17-010543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760217010543/form4.xml","form_type":"4"}}]}